Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
about
Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or BSoluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.Porcine factor VIII provides clinical benefit to patients with high levels of inhibitors to human and porcine factor VIII.A case report of the Modified Malmö Protocol: an alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura.Treatment options for bleeding episodes in patients undergoing immune tolerance therapy.Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodiesImmune tolerance induction: recombinant vs. human-derived product.Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practiceB-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.Inhibitors: resolving diagnostic and therapeutic dilemmas.Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.Donor specific antibodies after transplantationCost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in IranIgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.Immune tolerance therapy in patients with acquired hemophilia.Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach.Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells.Complications of hemophilia A treatment: factor VIII inhibitors.Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage.Factor VIII inhibitors: a 50-year perspective.Pharmacotherapy of haemophilia A.Immune tolerance induction in haemophilia: evidence and the way forward.Immune tolerance induction for patients with severe hemophilia A: a critical literature review.The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience.The reversal of inhibitors in congenital hemophilia.Factor VIII inhibitors in hemophilia A: rationale and latest evidenceImmunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B--a systematic literature review.ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.Current Practice in the Treatment of Haemophilia.Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study.Acquired haemophilia and its management.Indications for emergency apheresis procedures.B-cell tolerance in transplantation: is repertoire remodeling the answer?Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy.Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamide.Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT.Tolerance induction using the Malmö treatment model 1982-1995.Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors.Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
P2860
Q24195006-C65B66F3-B241-4B37-9EFB-42CED493A066Q33277868-69397F36-FE31-498A-BDD7-736DB456AE68Q33334440-187C2DB4-3446-47E4-9775-1A132A1CF8FCQ33379740-9F88AC0B-4FBA-4AC3-A80B-E03328AB7F61Q33794095-2EB60884-39B7-4009-BF03-590352B7269EQ33858625-6881153E-C26F-4FC2-A208-C3BC4D438887Q34117221-D8051332-442C-46EC-909F-5A5337E34D9FQ34157402-A223C6B0-48E1-415F-869B-0364C7008D51Q34159016-E0943F73-A881-473D-8257-E2C281FE902FQ34636988-5289279C-5DB2-45D4-BBDC-D8560B9114C1Q34801411-7465E2B8-A4D7-496A-9FD9-A3E9DE6246BCQ35388861-85AF474F-E5D5-44BE-B6EF-065AC57BC350Q35602600-1C7E390D-4D7D-40FD-9D52-15D20F2387D9Q35602714-C04416E8-B045-45CC-A967-B93A893C8502Q35994817-4C114F79-B834-4826-88B5-1050F39038FDQ36884360-4EC50EC7-933A-4B54-9FB4-352A7C25A813Q37012289-84AF9E02-4BDB-4A2D-B35F-6A3FB724B959Q37332201-5FC8768D-89A8-40F4-9023-4FC532099FD4Q37588914-2F227416-74F9-4805-833A-A541EE511856Q37876956-9C4E7535-346F-4CB2-8024-E39003805E66Q37891089-4632792E-EB7C-40F5-A71F-182460102303Q37903944-C450A252-978C-42AD-A625-610BD5380625Q37912059-649A45CD-2351-45CE-B0C6-A4C97581A9A9Q37924970-4D4D3142-D521-45DC-849E-9DB8891013BEQ38077139-8ECA2E20-E4CB-4FEA-A9AB-0123552C0997Q38101041-C7286B65-7A04-4630-AF37-CF54A0CB72EFQ38222574-804ED39D-2B06-41DB-A33F-7533BD82FE75Q38224296-25A6F838-5719-4A7C-BEE9-E5E6F727052FQ38894036-3C381AD7-50DD-4F68-A263-96C4880725BEQ39666092-206B152D-2C3F-43D3-8281-EA1C8C8F2F87Q40602765-D405C78B-F19E-4A13-B40A-5EA808773636Q41687664-F000B688-C994-493D-8BB0-AE9F172B6174Q42038591-D64954E3-D061-4554-9EAF-166E1148A6E0Q43831731-016C8936-0311-499B-A704-66604F6CC915Q43936457-180AB23E-1574-4280-B9D0-F8EF78C234FBQ45855060-5EC3E22F-ED4E-40C4-A9DA-4CC50A839E32Q45857739-78734226-492C-4287-A301-82E2C3577034Q45859168-AD3AE46B-FC03-43B0-999F-A2DD96B59DF1Q45863779-A4A8B471-3F81-469A-A93F-CD43771EB5EFQ45867232-88064A13-30DC-441F-8C5F-F1E633F4104F
P2860
Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Induction of immune tolerance ...... ophosphamide, and factor VIII.
@en
Induction of immune tolerance ...... ophosphamide, and factor VIII.
@nl
type
label
Induction of immune tolerance ...... ophosphamide, and factor VIII.
@en
Induction of immune tolerance ...... ophosphamide, and factor VIII.
@nl
prefLabel
Induction of immune tolerance ...... ophosphamide, and factor VIII.
@en
Induction of immune tolerance ...... ophosphamide, and factor VIII.
@nl
P2093
P921
P1476
Induction of immune tolerance ...... ophosphamide, and factor VIII.
@en
P2093
Berntorp E
Nilsson IM
Zettervall O
P304
P356
10.1056/NEJM198804143181503
P407
P577
1988-04-01T00:00:00Z